Oncology Archives - Page 2 of 3

Oct, 2014

Tumor Xenografting in Mouse Models: A Necessity for Cancer Drug Development

Posted on October 23, 2014 by Pharma Models Blogging Team in Oncology

Pre-clinical cancer research – specifically drug development – often uses a standard procedure called tumor xenografting. This method essentially injects human cancer cell lines into mice to learn more about the mechanisms behind tumor growth and for developing effective cancer drugs, a paper published in Nature magazine explained. Subcutaneous xenografts, however, may have some limitations, as they are unable […]

Oct, 2014

From Breast Cancer to the Epstein-Barr Virus, Cancer Vaccines are a Game Changer

Posted on October 21, 2014 by Pharma Models Blogging Team in Oncology

October is National Breast Cancer Awareness Month and, as such, it is time to shed some light on important breast cancer research. In 2010, Dr. Vincent Tuohy and colleagues from the Cleveland Clinic published a paper in Nature Medicine that shows a vaccine using the target protein alpha-lactalbumin was able to prevent breast cancer in […]

Oct, 2014

The Battle to End Ovarian Cancer Leads Researchers to Uncover Causes

Posted on October 07, 2014 by Pharma Models Blogging Team in Oncology

Ovarian cancer affects approximately 239,000 women annually, worldwide, and results in 152,000 deaths, predominantly in North America and Europe. It is the seventh most common cancer and eighth most common cause of death from cancer in women. A significant reason that ovarian cancer is so deadly is that it reaches an advanced stage before it […]

Sep, 2014

Obesity Across the Globe Leading to Serious Health Risks

Posted on September 25, 2014 by Pharma Models Blogging Team in Oncology

Headlines from the Centers for Disease Control and Prevention have emphasized the rise of obesity around the nation, with more than one-third of all U.S. adults classified as obese. The World Health Organization states that obesity has almost doubled worldwide since 1980. The Trust for America’s Health and the Robert Wood Johnson Foundation also released a […]

Sep, 2014

Leukemia: The Most Common Childhood Cancer

Posted on September 16, 2014 by Pharma Models Blogging Team in Oncology

While leukemia affects adults as well as children, leukemia is the most common cancer among children and teenagers, accounting for 34% of all childhood cancer. The majority of childhood leukemia is acute, the American Cancer Society expressed. This includes acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), and a hybrid of the two. ALL originates […]

Sep, 2014

Three Ways to Fight Chronic Lymphoblastic Leukemia

Posted on September 04, 2014 by Pharma Models Blogging Team in Oncology

Chronic lymphoblastic leukemia (CLL) is a common blood and bone marrow disease seen in adults. It is very rare for this disorder to affect children or adults younger than their mid-forties. Older white males are at higher risk of CLL as well as those with Eastern European Jewish descent. According to the National Cancer Institute, […]

Sep, 2014

How Animal Models Have Advanced Pancreatic Cancer Research

Posted on September 03, 2014 by Pharma Models Blogging Team in Oncology

Pancreatic cancer has one of the lowest 5-year survival rates and leads to approximately 40,000 deaths in the United States each year, the American Cancer Society reported. The survival rates of this disease are very low – only 6 percent of patients diagnosed with pancreatic cancer are alive five years later. However, incorporating animal models […]

Aug, 2014

The Symptoms and Treatments of Acute Lymphoblastic Leukemia

Posted on August 11, 2014 by Pharma Models Blogging Team in Oncology

Leukemia is a deadly disease that affects nearly 50,000 people within the United States every year, and accounts for 65% of all childhood cancers in the US. Acute lymphoblastic leukemia (ALL) has a peak incidence between 2 and 5 years of age, and is the least common type of leukemia found in adults, according to […]

Aug, 2014

Chronic Myeloid Leukemia: A Cancer Not Meant for Children

Posted on August 05, 2014 by Pharma Models Blogging Team in Oncology

Chronic Myeloid Leukemia (CML) is a cancer of the white blood cells that forms in the bone marrow and travels through the cardiovascular system. With this particular type of leukemia, it takes much longer to develop symptoms. In fact, it may be a few years before symptoms are showing, according to The American Cancer Society. […]

Jul, 2014

The Breast Cancer Drug Market Shoots for the Stars

Posted on July 28, 2014 by Pharma Models Blogging Team in Oncology

Breast cancer is a difficult diagnosis to receive for any woman, as this disease leads to approximately 40,000 deaths in the United States every year. Breast cancer also affects about one in eight women throughout a lifetime. The healthcare sector and cancer drug market has focused on developing better treatments over the years, which has […]

Tumor Xenografting in Mouse Models: A Necessity for Cancer Drug Development

Categories